More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro
Growing evidence indicates that pancreatic cancer stem cells (CSCs) contribute to cancer recurrence via chemoresistance, and their growth is sustained by self-renewal. Targeting the self-renewal of pancreatic CSCs is a crucial strategy to eradicate them. Here, we are the first to describe a known KR...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Published: |
Tech Science Press
2023
|
Online Access: | http://psasir.upm.edu.my/id/eprint/110161/ https://www.degruyter.com/document/doi/10.1515/oncologie-2023-0214/html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|